BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24409063)

  • 21. Age-Related Survival Differences in Patients With Inflammatory Bowel Disease-Associated Colorectal Cancer: A Population-Based Cohort Study.
    Bogach J; Pond G; Eskicioglu C; Seow H
    Inflamm Bowel Dis; 2019 Nov; 25(12):1957-1965. PubMed ID: 31066449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age.
    Trivedi PJ; Crothers H; Mytton J; Bosch S; Iqbal T; Ferguson J; Hirschfield GM
    Gastroenterology; 2020 Sep; 159(3):915-928. PubMed ID: 32445859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vulvar and vaginal neoplasia in women with inflammatory bowel disease.
    Rouvroye MD; Tack GJ; Mom CH; Lissenberg-Witte BI; Pierik MJ; Neefjes-Borst EA; de Boer NKH;
    Dig Liver Dis; 2020 Feb; 52(2):149-155. PubMed ID: 31718933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
    Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
    J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study.
    Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
    Lancet; 2001 Jan; 357(9252):262-6. PubMed ID: 11214128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Marín-Jiménez I; Gisbert JP; Pérez-Calle JL; García-Sánchez V; Tabernero S; García-Vicuña R; Romero C; Juliá B; Vanaclocha F; Cea-Calvo L;
    Gastroenterol Hepatol; 2015 Dec; 38(10):569-74. PubMed ID: 25983283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study.
    Bojesen RD; Riis LB; Høgdall E; Nielsen OH; Jess T
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1900-1907.e2. PubMed ID: 28694132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-year incidence of psoriasis, uveitis and inflammatory bowel disease in patients with spondyloarthritis: A study in the AQUILES cohort.
    García-Vicuña R; Zarco P; González CM; Vanaclocha F; Marín-Jiménez I; Cea-Calvo L
    Reumatol Clin; 2016; 12(1):22-6. PubMed ID: 25683367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease.
    García Rodríguez LA; Ruigómez A; Panés J
    Gastroenterology; 2006 May; 130(6):1588-94. PubMed ID: 16697722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for appendiceal and colorectal peritoneal metastases.
    Enblad M; Graf W; Birgisson H
    Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Appendiceal mucinous cystadenoma is a neoplastic complication of IBD: case-control study of primary appendiceal neoplasms.
    Orta L; Trindade AJ; Luo J; Harpaz N
    Inflamm Bowel Dis; 2009 Mar; 15(3):415-21. PubMed ID: 18989894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease.
    Nyboe Andersen N; Pasternak B; Basit S; Andersson M; Svanström H; Caspersen S; Munkholm P; Hviid A; Jess T
    JAMA; 2014 Jun; 311(23):2406-13. PubMed ID: 24938563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    Taborelli M; Sozzi M; Del Zotto S; Toffolutti F; Montico M; Zanier L; Serraino D
    PLoS One; 2020; 15(6):e0235142. PubMed ID: 32574216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Collins PD; Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiologic study on the current incidence of inflammatory bowel disease in Madrid.
    López-Serrano P; Pérez-Calle JL; Carrera-Alonso E; Pérez-Fernández T; Rodríguez-Caravaca G; Boixeda-de-Miguel D; Fernández-Rodríguez CM
    Rev Esp Enferm Dig; 2009 Nov; 101(11):768-72. PubMed ID: 20001154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mortality After First Hospital Admission for Inflammatory Bowel Disease: A Nationwide Registry Linkage Study.
    Opstelten JL; Vaartjes I; Bots ML; Oldenburg B
    Inflamm Bowel Dis; 2019 Sep; 25(10):1692-1699. PubMed ID: 31189013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of second cancers in patients with colorectal carcinoids.
    Tichansky DS; Cagir B; Borrazzo E; Topham A; Palazzo J; Weaver EJ; Lange A; Fry RD
    Dis Colon Rectum; 2002 Jan; 45(1):91-7. PubMed ID: 11786770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
    Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
    Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.